| Phase I trials, including: |
- Bioequivalence and bioavailability studies
- First-in-Man and dose-escalation studies
- Single- and multiple-dose studies
- Drug-drug and food-drug interaction studies
- Special population studies, including patients with impaired liver and kidney functions
|
| |
|
